MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
  •  

AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial

IRVINE, Calif. – January 16, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

ROOT OF SKIN™ Skincare Line Sells Out Again During Third Appearance on QVC Japan

IRVINE, Calif. – January 15, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical to Present at Biotech Showcase 2019

IRVINE, Calif. – January 3, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

ROOT OF SKIN™ Skincare Line Sells Out Again During Second Appearance on QVC Japan

IRVINE, Calif. – December 17, 2018 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical to Exhibit New ROOT OF SKIN™ MD Skincare Products at A4M World Congress

IRVINE, Calif. – December 12, 2018 – AIVITA Biomedical, Inc. today announced that it will be exhibiting at The…

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan

IRVINE, Calif. – November 28, 2018 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial

IRVINE, Calif. – November 16, 2018 – AIVITA Biomedical announced today that it has dosed the first two patients in…

AIVITA Biomedical to Exhibit ROOT OF CANCER Immunotherapy at 33rd SITC Annual Meeting

IRVINE, Calif. – November 7, 2018 – AIVITA Biomedical, Inc. today announced that the Company will present a next…

AIVITA Biomedical Consumer Skincare Line ROOT OF SKIN™ to Be Sold on Home Shopping Channel QVC Japan

IRVINE, Calif. – October 30, 2018 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical Enrolls First Patient in Phase 2 Glioblastoma Trial

IRVINE, Calif. – October 25, 2018 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

  • Previous
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target infectious diseases and tumor-initiating cells — the seed of all cancers — using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields.

Recent News

  • AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
  • AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress
  • AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2023 | AIVITA Biomedical, Inc.